Latest Insider Transactions at Organicell Regenerative Medicine, Inc. (OCEL)
This section provides a real-time view of insider transactions for Organicell Regenerative Medicine, Inc. (OCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organicell Regenerative Medicine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organicell Regenerative Medicine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.26 P/Share
|
|
May 12
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 12
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 11
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,100
-0.03%
|
$0
$0.31 P/Share
|
|
May 11
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.32 P/Share
|
|
May 11
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.35 P/Share
|
|
May 11
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.32 P/Share
|
|
May 10
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 07
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
89,900
-0.04%
|
$0
$0.25 P/Share
|
|
May 07
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 07
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
80,000
-0.03%
|
$0
$0.27 P/Share
|
|
May 07
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.02%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.05%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.02%
|
$0
$0.26 P/Share
|
|
May 05
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.05%
|
$0
$0.29 P/Share
|
|
May 05
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
75,000
-0.03%
|
$0
$0.29 P/Share
|
|
May 05
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.03%
|
$0
$0.3 P/Share
|
|
May 05
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.29 P/Share
|
|
May 04
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.42 P/Share
|
|
May 03
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.25 P/Share
|
|
Apr 30
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.47 P/Share
|
|
Apr 30
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.5 P/Share
|
|
Apr 30
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.5 P/Share
|
|
Apr 30
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.45 P/Share
|
|
Apr 29
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.48 P/Share
|
|
Apr 29
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.45 P/Share
|
|
Apr 06
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+2.87%
|
-
|
|
Apr 06
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.04%
|
-
|
|
Apr 06
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.22%
|
-
|
|
Apr 06
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.79%
|
-
|
|
Feb 28
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+0.61%
|
-
|
|
Feb 22
2021
|
Michael Carbonara Director |
BUY
Open market or private purchase
|
Direct |
1,818,181
+3.66%
|
$0
$0.06 P/Share
|
|
Feb 10
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.33%
|
-
|
|
Feb 10
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.83%
|
-
|
|
Feb 10
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+2.96%
|
-
|
|
Feb 10
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.21%
|
-
|
|
Jan 27
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.44%
|
-
|
|
Jan 27
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.86%
|
-
|
|
Jan 27
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.05%
|
-
|
|
Jan 27
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.39%
|
-
|
|
Dec 21
2020
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000,000
+8.87%
|
-
|
|
Dec 21
2020
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000,000
+9.98%
|
-
|